Sara Rodriguez-Gonzalez

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Corrigendum to: "Involvement of protein A and IL-16 in the hyperalgesia and allodynia evoked by Staphylococcus aureus in mice" [Eur J Pharmacol. 2025 1002:177861].

Corrigendum to: "Involvement of protein A and IL-16 in the hyperalgesia and allodynia evoked by Staphylococcus aureus in mice" [Eur J Pharmacol. 2025 1002:177861].

Journal: European journal of pharmacology

Published: July 04, 2025

Involvement of protein A and IL-16 in the hyperalgesia and allodynia evoked by Staphylococcus aureus in mice.

Involvement of protein A and IL-16 in the hyperalgesia and allodynia evoked by Staphylococcus aureus in mice.

Journal: European journal of pharmacology

Published: January 10, 2025

Editorial: Use of Artificial Intelligence to evaluate drug-related behavioral changes in rodents.

Editorial: Use of Artificial Intelligence to evaluate drug-related behavioral changes in rodents.

Journal: Frontiers in pharmacology

Published: March 05, 2024

Hyperalgesic Effect Evoked by il-16 and its Participation in Inflammatory Hypernociception in Mice.

Hyperalgesic Effect Evoked by il-16 and its Participation in Inflammatory Hypernociception in Mice.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: February 01, 2024

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity.

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity.

Journal: International journal of molecular sciences

Published: August 31, 2023

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

Journal: Cancer immunology, immunotherapy : CII

Published: November 11, 2022

β-Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models.

β-Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models.

Journal: International journal of molecular sciences

Published: January 25, 2022

Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice.

Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice.

Journal: Life sciences

Published: July 07, 2021

DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target.

DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target.

Journal: Bioorganic chemistry

Published: April 30, 2021

Kappa-opioid receptor-mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice.

Kappa-opioid receptor-mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice.

Journal: Fundamental & clinical pharmacology

Published: October 27, 2020

Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.

Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.

Journal: Journal of medicinal chemistry

Published: August 14, 2020

Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.

Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.

Journal: Scientific reports

Published: May 13, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026